I'm not one to speculate numbers, but I will say whether we get approval or need phase 3 for m/m trial, if the data is amazing BP will be at the door, this is a worldwide pandemic that is gaining momentum and closing economies. Money will come. Whether it is for use on just Covid, or BP would want more of Cytodyn is to be learned. But Covid use will sell out. I don't see us going at this alone.
Hey B-Ops, Putting your numbers together, I am getting let’s say 5Bx($0.5)x100P/E=$250B, and considering ~800M shares, the SP will be at $312.50 for HIV alone! Which also puts CYDY above the top five BP combined together. Did I miss something?!
News 
Market Data 
Discover 
